MBX Biosciences, Inc. (MBX)
Healthcare
Biotechnology
65.90 $
-0.8%
vs. previous close
Closing price · As of: 31. Jul 2026
MBX Biosciences, Inc. (MBX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -20 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.4 | -7.7 | -11 | -11 | -13 | -15 | -16 | -23 | -17 | -22 | -18 | -20 | -77 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | -1.0 | 0.1 | 0.9 | -0.6 | -0.6 | |
| 0.2 | 0.6 | 1.0 | 1.6 | 0.9 | 1.2 | 1.5 | 1.8 | 1.9 | 2.2 | 2.7 | 5.5 | 12 | |
| 0.1 | 1.8 | -2.9 | 0.4 | 2.0 | 2.8 | -0.6 | 0.6 | 0.9 | -1.5 | 1.6 | -1.7 | -0.7 | |
| 0.0 | 0.0 | 0.1 | 0.3 | 0.5 | 0.1 | 0.1 | 0.0 | 0.7 | 0.4 | 0.8 | 0.4 | 2.3 | |
| 20 | -19 | -29 | 15 | -7.9 | -101 | -67 | 3.2 | 26 | 17 | -130 | -97 | -184 | |
| 0.6 | 68 | 0.0 | 0.2 | -1.8 | 236 | -0.1 | 0.0 | 1.3 | 188 | 0.4 | 87 | 277 | |
| 13 | 42 | -40 | 35 | -23 | 120 | -84 | -19 | 9.9 | 183 | -148 | -30 | 16 | |
| -7.4 | -7.7 | -11 | -11 | -14 | -15 | -16 | -23 | -18 | -22 | -19 | -21 | -80 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.